Page last updated: 2024-10-29

iohexol and Anemia, Sickle Cell

iohexol has been researched along with Anemia, Sickle Cell in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zantomio, D1
Dowling, RJ1
Grigg, A1
Losco, P1
Nash, G1
Stone, P1
Ventre, J1

Other Studies

2 other studies available for iohexol and Anemia, Sickle Cell

ArticleYear
Cerebral vaso-occlusive event with low-osmolar intravenous contrast in a patient with sickle cell disease.
    American journal of hematology, 2006, Volume: 81, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Carotid Arteries; Cerebrovascular Disorders; Contrast Media; Female; Hum

2006
Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S.
    American journal of hematology, 2001, Volume: 68, Issue:3

    Topics: Anemia, Sickle Cell; Blood Donors; Contrast Media; Dose-Response Relationship, Drug; Erythrocyte Ind

2001